PMC:7696151 / 46782-46997
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1327 | 195-198 | Chemical | denotes | HCQ | MESH:D006886 |
| 1339 | 116-124 | Disease | denotes | diabetic | MESH:D003920 |
| 1340 | 146-166 | Disease | denotes | rheumatoid arthritis | MESH:D001172 |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T79 | 146-166 | Phenotype | denotes | rheumatoid arthritis | http://purl.obolibrary.org/obo/HP_0001370 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T301 | 0-215 | Sentence | denotes | However, apparent different outcomes were derived from a randomized double-blind crossover trial, recruiting 23 non-diabetic subjects with stable rheumatoid arthritis to receive 6.5 mg/kg/day of HCQ for eight weeks. |